Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in Cairo, Egypt

Australian Journal of Basic and Applied Sciences

Volumn 4, Issue 3, 2010, Pages 398-407

  Salem, Mounir M ^a   Muharram, Magdy ^b   Alhosiny, Ibrahim M ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Drug resistance; E. coli; Multidrug resistant (MDR) bacteria; Risk factors; Urinary tract infections

Indexed keywords

EID: 77953004694     PISSN: 19918178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Aguiar, J.M., J. Chacon, R. Canton and F. Baquero, 1992. The emergence of highly fluoroquinoloneresistant Escherichia coli in community-acquired urinary tract infections. J. Antimicrob. Chemother, 29: 349-350.
2. Akinkugbe, F.M., F.P. Familusi and O. Akinkugbe, 1973. Urinary Tract Infection in Infancy and early Childhood. East Afr. Med. J., 59(9): 514-520.
3. Al-Agamy, M.H., M.S. Ashour and I. Wiegand, 2006. First description of CTX-M ß- lactamase-producing clinical Escherichia coli isolates from Egypt. Int. J. Ant. Microb. Agents, 27: 545-548.
4. Arakawa, Y., M. Murakami, K. Suzuki, H. Ito, R. Wacharotayankun, S. Ohsuka, N. Kato and M. Ohta, 1995. A novel integron-like element carrying the metallo-_-lactamase gene blaIMP. Antimicrob. Agents Chemother., 39: 1612-1615.
5. Arakawa, Y., M. Murakami, K. Suzuki, H. Ito, R. Wacharotayankun, S. Ohsuka, N. Kato and M. Ohta, 1995. A novel integrons like element carrying the metallobetalactamase gene bla IMP. Antimicrob. Agents. Chemother, 39: 1612-1615.
6. Asour, H.M. and A. Elsharif, 2009. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J. Trans. Med., 7: 1-14.
7. Barlow, R.S., J.M. Pemberton, P.M. Desmarchelier and K.S. Gobius, 2004. Isolation and characterization of integron-containing bacteria without antibiotic selection. Antimicrob. Agents Chemother, 48: 83-8842.
8. Barlow, R.S., N. Fegan and K.S. Gobius, 2008. A comparison of antibiotic resistance integrons in cattle from separate beef meat production systems at slaughter. J. Appl. Microbiol., 104: 651-658.
9. Birski, L. and D. Mazel, 2003. Erythromycin esterase gene ere (A) is located in a functional gene cassette in an unusual class 2 integron. Antimicrob. Agents. Chemother., 47: 3326-3331.
10. Bonnet, R., 2004. Growing group of extended-spectrum â-lactamases: The CTX-M enzymes. Antimicrob. Agents. Chemother., 48: 1-14.
11. Bonnet, R., 2004. Growing group of extended-spectrum â-lactamases: The CTX-M enzymes. Antimicrob. Agents. Chemother., 48: 1-14.
12. Boucher, Y., M. Labbate, J.E. Koenig and H.W. Stokes, 2007. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends Microbiol., 15: 301-309.
13. Brown, P.D., A. Freeman and B. Foxman, 2002. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan., Clin. Infect. Dis., 34: 1061-1066.
14. Calbo, E., V. Romani, M. Xercavins, L. Gomez, C.G. Vidal, S. Quintana, J. Vila and J. Garau. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum betalactamases. J. Antimicrob. Chemother, 57: 780-783.
15. Canton, R., T.M. Coque and F. Baqueero, 2003. Multi-resistant Gramnegative bacilli: From epidemics to endemics. Curr. Opin. Infect. Dis., 16: 315-325.
16. Corinna, K., D.J. Anno, F. Sonja, C. Axel and S. Schwarz, 2007. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J. Antimicrob. Chemother, 59: 886 - 892.
17. Dromigny, J.A., P. Nabeth, A. Juergens-Behr and J.D. Perrier-Gros-Claude, 2005. Risk factors for antibiotic resistant Escherichia coli isolated from community acquired urinary tract infections in Dakar, Senegal. J. Antimicrob. Chemother, 56: 236-239.
18. Ena, J., P.M. Lopez, C. Martinez, B.M. Cia, I. Remiz-Lopez, 1998. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of quinolones. Diagn. Microbiol. Infect. Dis., 30: 103-107.
19. Epoke, C.O., G.O. Anyanwu and A.A. Opara, 2000. The Prevalence of Significant Bacteriuria in Diabetic Patients. Diab. Int., 10: 16-17.
20. Foxman, B., 2008. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med., 113(Suppl. 1A): 5S-13S.
21. Franklin, G.A., K.B. Moore, J.W. Snyder, H.C. Jr Polk and W.G. Cheadle, 2002. Emergence of resistant microbes in critical care units in transient, despite an unrestricted formulary and multiple antibiotic trials. Surg. Infect., 3(2): 135-144.
22. Garau, J., 2008. Other antimicrobials of interest in the era of extended spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect., 14(Suppl 1): 198-202.
23. Gaynes, R. and Edwards, J.R. 2005. Overview of nosocomial infectionscaused by gram-negative bacilli. Clin. Infect. Dis., 41: 848.
24. Goettsch, W., W. Van-Pelt, M. Nagelkerke, M.G.R. Hendrix, A.G.M. Buiting and P.L. Petit, 2000. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands. J. Antimicrob. Chemother, 46: 223-228.
25. Goossens, H., M. Ferech, S.R. Vander and M. Elseviers, 2005. M. ESAC Project Group. Outpatient antibiotic use in Europe and associationwith resistance: a cross-national database study. Lancet., 365: 579-87.
26. Gupta, K., D.F. Sahm and D. Mayfield, 2001. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin. Infect. Dis., 33: 89-94.
27. Haider, K., M.I. Huq, K.A. Talukder and Q.S. Ahmed, 1989. Electropherotyping of plasmid deoxyribonucleic acid (DNA) of different serotypes of Shigella flexneri strains isolated in Bangladesh. Epidem. Infect., 102: 421-428.
28. Hall, R.M., C.M. Collis, M.J. Kim, S.R. Partridge, G.D. Recchia and H.W. Stokes, 1999. Mobile gene cassettes and integrons in evolution. Ann. N.Y. Acad. Sci., 870: 68-80.
29. Hall, R.M., H.J. Brown, D.E. Brookes and H.W. Stokes, 1994. Integrons found in different locations have identical 5_ ends but variable 3_ ends. J. Bacteriol., 176: 6286-6294.
30. Hansson, K., L. Sundstrom, A. Pelletier and P.H. Roy, 2002. IntI2 integron integrase in Tn7. J. Bacteriol., 184: 1712-1721.
31. Hinnebush, J. and K. Tilly, 1993. Linear plasmids and chromosomes in bacteria. Mol. Microbiol., 10: 917-922.
32. Ho, P., Y. King-Sun, C. Kin-Hung, Y.C. Janice, Q. Tak-Lun and Y. Kwok-yung, 2010. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diag. Microbiol. Inf. Dis., 66: 87-93.
33. Huang, E.S. and R.S. Stafford, 2002. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch. Intern. Med., 162: 41-7.
34. Ish-Horowicz, D. and J.F. Burke, 1981. Rapid and efficient cosmid cloning. Nucleic Acids Res., 9(13): 2989-2998.
35. Joseph, F., T. Ervin, F. Michael, J.M. Richard, B.G. William and I.C. Ivanand, 2008. The Incidence of Fluoroquinolone Resistant Infections After Prostate Biopsy-Are Fluoroquinolones Still Effective Prophylaxis? J. Uorology, 179: 952-955.
36. Kadlec, K. and S. Schwarz, 2008. Analysis and distribution of class 1 and class 2 integrons and associated gene cassettes among Escherichia coli isolates from swine, horses, cats and dogs collected in the BfT-GermVet monitoring study. J. Antimicrob. Chemother, 62: 469-473.
37. Kallen, R., D. Skurnik, G.B. Pier, A. Andremont, A. Szmigielska, G. Krzemien, M. Roszkowska-Blaim, J.C. Craig,G.J. Williams and J.M. Simpson, 2010. Antibiotic prophylaxis and recurrent urinary tract infection in children. New Eng. J. Med., 362: 555-556.
38. Kurt, G., A. Naber, S.B. Giancarlo, B.C. Henry, P.D. Juan and M. Teresita, 2008. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. European Urology., 54: 1164-1178.
39. Liebert, C.A., R.M. Hall and A.O. Summers, 1999. Transposon Tn21, flagship of the floating genome. Microbiol. Mol. Biol. Rev., 63: 507-522.
40. Livermore, DM., 1995. b-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev., 8: 557-584.
41. Luzzaro, F., E.F. Vigano, D. Fossati, A. Grossi, A. Sala, C. Sturla, M. Saudelli, A. Toniolo, 2002. Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur. J. Clin. Microbiol. Infect. Dis., 21: 849-855.
42. Meng, J., S. Zhao, M.P. Doyle and S.W. Joseph, 1998. Antibiotic resistance of Escherichia coli O157:H7 and O157: NM isolated from animals, food, and humans. J. Food Prot., 61: 1511-1514.
43. NCCLS, 2006. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard. NCCLS document M100-S16. National Committee for Clinical Laboratory Standards (NCCLS), Wayne, Pensylvenia.
44. Nicolle, L.E., 2001. Epidemiology of urinary tract infection. Infect. Med., 18: 153-62.
45. Ojiegbe, G.C. and W.C. Nworie, 2000. Asymtomatic Bacteriuria among School Pupils in Enugu Urban Areas. J. Med. Sci., 9(1): 42-46.
46. Oteo, J., J. Campos an F. Baquero, 2001. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System. J. Antimicrob. Chemother, 50: 945-952.
47. Perrin, M., P.Y. Donnio, C. Heurtin-Lecorre, M.F. Travert and J.L. Avril, 1999. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals. J. Hosp. Infect., 41: 273-979.
48. Ranjbar, R., A. Aleo, G.M. Giammanco, A.M. Dionisi, N. Sadeghifard and C. Mammina, 2007. Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002-2003. BMC Infect. Dis., 7: 62.
49. Rodriguez-Bano, J., M.D. Navarro and L. Romero, 2006. Clinical and molecular epidemiology of extendedspectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin. Infect. Dis., 42: 37-45.
50. Rowe-Magnus, D.A. and D. Mazel, 2002. The role of integrons in antibiotic resistance gene capture. Int. J. Med. Microbiol., 292: 115-125.
51. Sahm, D.F., C. Thornsberry, D.C. Mayfield, M.E. Jones and J.A. Karlowsky, 2000. Multi-drug resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents. Chemother., 45: 1402-1406.
52. Shapiro, J.A., 1999. Views about evolution are evolving. Am. Soc. Microbiol. News, 65: 201-207.
53. Solberg, O.D., R.M. Ajiboye and L.W. Riley, 2006. Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli. J. Clin. Microbiol., 44: 1347-1351.
54. Soulsby, L., 2005. Resistance to antimicrobials in humans and animals. Br. J. Med., 331: 1219-1220.
55. Stamm, W.E., 2002. Scientific and Clinical Challenges in the Management of Urinary Tract Infections. Ame. J. Med., 113: 1s-4s.
56. Villa, L., C. Pezzella, F. Tosini, P. Visca A., Petrucca and A.Carattoli, 2000. Multiple-antibiotic resistance mediated by structurally related IncL/ M plasmids carrying extended-spectrum beta-lactamase gene and a class 1 integron. Antimicrob. Agents Chemother., 48: 2911-2914.
57. Yu, H.S., J.C. Lee, H.Y. Kang, D.W. Ro, J.Y. Chung, Y.S. Jeong, S.H. Tae, C.H. Choi, E.Y. Lee, S.Y. Seol, Y.C. Lee and D.T. Cho, 2003. Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades. J. Clin. Microbiol., 41: 5429-5433.